IL205999A0 - Reversible pegylated drugs - Google Patents
Reversible pegylated drugsInfo
- Publication number
- IL205999A0 IL205999A0 IL205999A IL20599910A IL205999A0 IL 205999 A0 IL205999 A0 IL 205999A0 IL 205999 A IL205999 A IL 205999A IL 20599910 A IL20599910 A IL 20599910A IL 205999 A0 IL205999 A0 IL 205999A0
- Authority
- IL
- Israel
- Prior art keywords
- pegylated drugs
- reversible pegylated
- reversible
- drugs
- pegylated
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL205999A IL205999A (en) | 2003-04-08 | 2010-05-26 | Reversible pegylated drugs |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46081603P | 2003-04-08 | 2003-04-08 | |
PCT/IL2004/000321 WO2004089280A2 (en) | 2003-04-08 | 2004-04-08 | Reversible pegylated drugs |
IL205999A IL205999A (en) | 2003-04-08 | 2010-05-26 | Reversible pegylated drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
IL205999A0 true IL205999A0 (en) | 2010-11-30 |
IL205999A IL205999A (en) | 2016-06-30 |
Family
ID=43570578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL205999A IL205999A (en) | 2003-04-08 | 2010-05-26 | Reversible pegylated drugs |
Country Status (1)
Country | Link |
---|---|
IL (1) | IL205999A (en) |
-
2010
- 2010-05-26 IL IL205999A patent/IL205999A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
IL205999A (en) | 2016-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1620118E (en) | Reversible pegylated drugs | |
IL170758A0 (en) | 7-amino-isoindolyl compounds and their pharmaceutical uses | |
GB0302671D0 (en) | Pharmaceutical formulations | |
IL172824A0 (en) | Pharmaceutical formulations | |
GB0302672D0 (en) | Pharmaceutical formulations | |
GB0206505D0 (en) | Pharmaceutical combination | |
GB0314733D0 (en) | Medicaments | |
GB0308968D0 (en) | Medicaments | |
GB0316341D0 (en) | Pharmaceutical formulations | |
GB2401043B (en) | Drug | |
GB0316889D0 (en) | Pharmaceutical agents | |
GB0201520D0 (en) | Pharmaceutical uses | |
PL373409A1 (en) | Pharmaceutical combination | |
IL245895A0 (en) | Reversible pegylated drugs | |
IL205999A0 (en) | Reversible pegylated drugs | |
EP1679067A4 (en) | Concurrent drugs | |
EP1594507A4 (en) | Novel antiherpes drug combinations | |
EP1624073A4 (en) | Drug | |
GB0316335D0 (en) | Pharmaceutical formulations | |
GB0312479D0 (en) | Pharmaceutical combination | |
GB0308469D0 (en) | Pharmaceutical combination | |
GB0308097D0 (en) | Insoluble drugs | |
GB0224680D0 (en) | Pharmaceutical | |
GB0220451D0 (en) | Pharmaceutical use | |
GB0327913D0 (en) | Medicament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |